Insmed (INSM) Operating Leases (2019 - 2026)
Insmed (INSM) posted quarterly Operating Leases of $9.8 million for Q1 2026, up 16.0% year-over-year from $8.5 million in Q1 2025, and down 19.2% quarter-over-quarter from $12.2 million in Q4 2025.
Insmed (INSM) Operating Leases (2019 - 2026) Analysis & Trends
Insmed's Operating Leases history runs 8 years deep, the most recent figure standing at $9.8 million for Q1 2026.
- In Q1 2026, Operating Leases rose 16.0% year-over-year to $9.8 million; the TTM figure through Mar 2026 stood at $9.8 million (up 16.0% YoY), while the FY2025 annual figure was $12.2 million, up 33.6% from the prior year.
- Operating Leases for Q1 2026 stood at $9.8 million, down from $12.2 million in the prior quarter.
- The five-year high for Operating Leases was $19.9 million in Q1 2022, with the low at $7.6 million in Q3 2025.
- The 5-year median for Operating Leases is $12.2 million (2025), against an average of $12.4 million.
- Peak annual rise in Operating Leases reached 33.6% in 2025, while the deepest fall reached 38.59% in 2025.
- Insmed's Operating Leases stood at $14.9 million in 2022, then dropped by 25.85% to $11.0 million in 2023, then retreated by 17.26% to $9.1 million in 2024, then surged by 33.6% to $12.2 million in 2025, then decreased by 19.2% to $9.8 million in 2026.
- Business Quant data shows INSM's Operating Leases at $9.8 million in Q1 2026, $12.2 million in Q4 2025, and $7.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.66 Mn |
| Mar 31, 2026 | 9.84 Mn |
| Dec 31, 2025 | 12.17 Mn |
| Sep 30, 2025 | 7.59 Mn |
| Jun 30, 2025 | 7.90 Mn |
| Mar 31, 2025 | 8.48 Mn |
| Dec 31, 2024 | 9.11 Mn |
| Sep 30, 2024 | 9.69 Mn |
| Jun 30, 2024 | 11.67 Mn |
| Mar 31, 2024 | 13.81 Mn |
| Dec 31, 2023 | 11.01 Mn |
| Sep 30, 2023 | 13.02 Mn |
| Jun 30, 2023 | 12.87 Mn |
| Mar 31, 2023 | 14.53 Mn |
| Dec 31, 2022 | 14.85 Mn |
| Sep 30, 2022 | 16.50 Mn |
| Jun 30, 2022 | 18.20 Mn |
| Mar 31, 2022 | 19.88 Mn |
| Dec 31, 2021 | 21.44 Mn |
| Sep 30, 2021 | 22.65 Mn |